We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


OctoPlus Announces Expansion of Drug Delivery Contract

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "OctoPlus Announces Expansion of Drug Delivery Contract"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

OctoPlus has performed feasibility work for previous compounds of this client in 2009 and 2010 and those studies have been successful. Pre-clinical studies performed with the prototype controlled release formulation were also successful.

Under the contract announced today, we will develop a controlled release formulation that combines the client's optimized product candidate with our proprietary drug delivery technology PolyActive®. If the project is successful, the contract may progress to a full process development and manufacturing contract, and a licensing agreement.